| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |